WARRANT TO PURCHASE SHARES OF COMMON STOCK OF HEART TEST LABORATORIES, INC. Void afterHeart Test Laboratories, Inc. • February 28th, 2022 • Orthopedic, prosthetic & surgical appliances & supplies • Texas
Company FiledFebruary 28th, 2022 Industry JurisdictionTHIS CERTIFIES THAT, for value received, , or their registered successors or assigns (hereinafter, the “Holder”), is entitled to purchase, subject to the conditions set forth below, at any time or from time to time during the Exercise Period (as defined in subsection 1.1 below), ( ) fully-paid and non-assessable shares (the “Shares”) of the common stock, par value $0.001 per share (the “Common Stock”), of Heart Test Laboratories, Inc., a Texas corporation (the “Company”), at an exercise price of $0.25 per share, subject to adjustment as provided in Section 3 below (the “Exercise Price”).
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF HEART TEST LABORATORIES, INC. Void after September 30, 2026Heart Test Laboratories, Inc. • February 28th, 2022 • Orthopedic, prosthetic & surgical appliances & supplies • Texas
Company FiledFebruary 28th, 2022 Industry JurisdictionTHIS CERTIFIES THAT, for value received, [Name], or their registered successors or assigns (hereinafter, the “Holder”), is entitled to purchase, subject to the conditions set forth below, at any time or from time to time during the Exercise Period (as defined in subsection 1.1 below), [Number] (Number in words) fully-paid and non-assessable shares (the “Shares”) of the common stock, par value $0.001 per share (the “Common Stock”), of Heart Test Laboratories, Inc., a Texas corporation (the “Company”), at an exercise price which is the lower of: (i) $0.1833 per share or (ii) a 30% discount to the price at which a closing of an offering for the sale of shares of Common Stock to the public (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Common Stock), in an initial public offering pursuant to an effective registration statement under the Securities Act of 1933, subject to adjustment as pro
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF BEAMZ INTERACTIVE, INC. Void after ______, 2017Beamz Interactive Inc • October 24th, 2014 • Household audio & video equipment • Delaware
Company FiledOctober 24th, 2014 Industry JurisdictionTHIS CERTIFIES THAT, for value received, ___________________, a _____________, or its registered successors or assigns (hereinafter, the “Holder”), is entitled to purchase, subject to the conditions set forth below, at any time or from time to time during the Exercise Period (as defined in subsection 1.1 below), _________________ (_____________) fully-paid and non-assessable shares (the “Shares”) of the common stock, par value $0.001 per share (the “Common Stock”), of Beamz Interactive, Inc., Inc., a Delaware corporation (the “Company”), at an exercise price of $0.02 per share, subject to adjustment as provided in Section 3 below (the “Exercise Price”).
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF BEAMZ INTERACTIVE, INC. Void after May __, 2016Beamz Interactive Inc • May 15th, 2013 • Household audio & video equipment • Delaware
Company FiledMay 15th, 2013 Industry JurisdictionTHIS CERTIFIES THAT, for value received, ___________________, a _____________, or its registered successors or assigns (hereinafter, the “Holder”), is entitled to purchase, subject to the conditions set forth below, at any time or from time to time during the Exercise Period (as defined in subsection 1.1 below), _________________ (_____________) fully-paid and non-assessable shares (the “Shares”) of the common stock, par value $0.001 per share (the “Common Stock”), of Beamz Interactive, Inc., Inc., a Delaware corporation (the “Company”), at an exercise price of $0.02 per share, subject to adjustment as provided in Section 3 below (the “Exercise Price”).
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF WOUND MANAGEMENT TECHNOLOGIES, INC. Void after __________, 2017Wound Management Technologies, Inc. • July 19th, 2012 • Orthopedic, prosthetic & surgical appliances & supplies • Texas
Company FiledJuly 19th, 2012 Industry JurisdictionTHIS CERTIFIES THAT, for value received, ____________________, or its registered successors or assigns (hereinafter, the “Holder”), is entitled to purchase, subject to the conditions set forth below, at any time or from time to time during the Exercise Period (as defined in subsection 1.1 below), ____________________ (___________) fully-paid and non-assessable shares (the “Shares”) of the common stock, par value $0.001 per share (the “Common Stock”), of Wound Management Technologies, Inc., a Texas corporation (the “Company”), at an exercise price of $0.15 per share, subject to adjustment as provided in Section 3 below (the “Exercise Price”).
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF beamz interactive, Inc.Beamz Interactive Inc • April 19th, 2012 • Delaware
Company FiledApril 19th, 2012 JurisdictionTHIS CERTIFIES THAT, for value received, ___________________, a _____________, or its registered successors or assigns (hereinafter, the “Holder”), is entitled to purchase, subject to the conditions set forth below, at any time or from time to time during the Exercise Period (as defined in subsection 1.1 below), _________________ (_____________) fully-paid and non-assessable shares (the “Shares”) of the common stock, par value $0.001 per share (the “Common Stock”), of Beamz Interactive, Inc., Inc., a Delaware corporation (the “Company”), at an exercise price of $0.02 per share, subject to adjustment as provided in Section 3 below (the “Exercise Price”).